CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 226 enrolled
Drug / intervention
CGM+BGM +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02258373
NCT02258373N/ACompleted
CompareCT.gov

A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes

Jaeb Center for Health Research·interventional·Posted Oct 7, 2014·Updated Aug 9, 2018

In Brief

A clinical study evaluating CGM+BGM and CGM Only for Type 1 Diabetes. Completed, enrolled 226 participants across 14 sites.

Detailed Summary

The primary objective of the study is to determine whether the routine use of Continuous Glucose Monitoring (CGM) without Blood Glucose Monitoring (BGM) confirmation is as safe and effective as CGM used as an adjunct to BGM.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 7, 2014
Enrollment StartMar 1, 2015
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.7 years ago

Interventions

CGM+BGMdevice

Dexcom G4 Platinum Continuous Glucose Monitoring System with modified algorithm + Abbot Precision Xtra Blood Glucose-Ketone Meter

CGM Onlydevice

Dexcom G4 Platinum Continuous Glucose Monitoring System with modified algorithm